http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112336717-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 |
| filingDate | 2020-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112336717-B |
| titleOfInvention | Application of Yinkuiseting in the preparation of medicine for preventing and treating porcine reproductive and respiratory syndrome |
| abstract | The invention discloses the application of Yinkuisetin in preparing a medicine for preventing and treating porcine reproductive and respiratory syndrome, and belongs to the field of medicine. The present invention studies the antiviral effect of Yinkuishetin on PRRSV at the level of Marc-145 and PAM cells through methods such as qRT-PCR, Western Blot, and determination of progeny virus TCID 50 and IFA in cell supernatant. Quercetin significantly inhibited the proliferation of PRRSV in its susceptible cells Marc-145 and host target cells PAM, and its antiviral effect increased with increasing concentration. The invention proves that the Yinkuisheting preparation has good antiviral effect, and is expected to become a new type of medicine for preventing and treating porcine reproductive and respiratory syndrome. |
| priorityDate | 2020-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 141.